Chief Investigator: Professor Dame Lesley Fallowfield

Co-Investigators: Dr Val Jenkins, Rachel Starkings

Data Manager: Shirley May

Funded by: Breast Cancer Research Foundation

Recurrence scores from gene expression profiling tests are used increasingly to determine the likely benefit of adjuvant chemotherapy in early stage breast cancer. Discussions with anxious patients about risk and uncertainty and the rationale for different treatment recommendations can be complex and confusing. The TARGET research programme aims to assist clinicians with these conversations.

^ Top